ABSCI CORPORATION - COMMON STOCK

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

18 Feb 2025 07:00:00 By Nasdaq GlobeNewswire

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

22 Jan 2025 07:00:00 By Nasdaq GlobeNewswire

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

10 Jan 2025 06:30:00 By Nasdaq GlobeNewswire

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

08 Jan 2025 06:00:00 By Nasdaq GlobeNewswire

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

06 Jan 2025 07:00:01 By Nasdaq GlobeNewswire

Absci to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

02 Jan 2025 07:00:00 By Nasdaq GlobeNewswire

Absci Highlights Progress and Updates Across Proprietary Pipeline and Leading AI Platform at 2024 R&D Day

12 Dec 2024 07:00:00 By Nasdaq GlobeNewswire

Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference

21 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

12 Nov 2024 06:30:00 By Nasdaq GlobeNewswire

Absci to Host R&D Day on December 12, 2024

07 Nov 2024 07:00:01 By Nasdaq GlobeNewswire

Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI

31 Oct 2024 07:00:00 By Nasdaq GlobeNewswire

Absci to Participate in Upcoming Investor Conferences

24 Oct 2024 07:00:00 By Nasdaq GlobeNewswire

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

15 Oct 2024 07:00:00 By Nasdaq GlobeNewswire

Absci to Participate in Upcoming Investor Conferences

21 Aug 2024 07:00:00 By Nasdaq GlobeNewswire

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

14 Aug 2024 15:01:00 By Nasdaq GlobeNewswire

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

12 Aug 2024 07:00:00 By Nasdaq GlobeNewswire

Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

10 Jul 2024 07:00:00 By Nasdaq GlobeNewswire

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

03 Jul 2024 15:00:00 By Nasdaq GlobeNewswire

Absci to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit

12 Jun 2024 07:00:00 By Nasdaq GlobeNewswire

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

28 May 2024 07:00:00 By Nasdaq GlobeNewswire